C. Masurier

发表

Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.

C. Leborgne, S. Boutin, F. Mingozzi, 2019, Cellular immunology.

Immunity and tolerance induction in gene therapy

J. Davoust, N. Bertho, D. Gross, 2005 .

CHAPTER 18 – NK cells

L. Zitvogel, E. Maraskovsky, M. Terme, 2001 .

Efficient transduction of monocyte‐ and CD34+‐ derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation

J. Davoust, O. Danos, S. Boutin, 2006, The journal of gene medicine.

A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8.

C. Leborgne, S. Boutin, O. Benveniste, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients.

R. Kotin, L. Servais, J. Hogrel, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

BCR/ABL promotes dendritic cell-mediated natural killer cell activation.

E. Wagner, L. Zitvogel, A. Bernheim, 2005, Cancer research.

Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats.

D. Heudes, M. Bélair, J. Bariéty, 1997, Kidney international.

Cellular but not humoral immune responses generated by vaccination with dendritic cells protect mice against leukaemia

D. Klatzmann, C. Pioche-Durieu, F. M. Lemoine, 2000, Immunology.

Three populations of mouse lymph node dendritic cells with different origins and dynamics.

D. Klatzmann, B. Salomon, J. Cohen, 1997, Journal of immunology.

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.

N. Romero, D. Klatzmann, R. Mulligan, 2012, Brain : a journal of neurology.

Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy

R. Grange, A. Beggs, D. Mack, 2014, Science Translational Medicine.

Childers Canine Models of Myotubular Myopathy Gene Therapy Prolongs Survival and Restores Function in Murine and

R. Grange, A. Beggs, D. Mack, 2014 .

Three populations of mouse lymph node dendritic cells with different origins and dynamics.

D. Klatzmann, B. Salomon, J. Cohen, 1997, Journal of immunology.

Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation

J. Davoust, J. Plumas, L. Chaperot, 2009, Journal of Translational Medicine.

Enhanced lentiviral transduction of monocyte-derived dendritic cells in the presence of conditioned medium from dying monocytes.

J. Davoust, O. Danos, S. Boutin, 2007, Human gene therapy.

Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2

A. Douar, V. Allo, P. Véron, 2007, Journal of Virology.

Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors

C. Leborgne, S. Boutin, P. Véron, 2012, The Journal of Immunology.

Polymers for Improving the In Vivo Transduction Efficiency of AAV2 Vectors

D. Scherman, A. Kichler, S. Boutin, 2010, PloS one.

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors

Laetitia van Wittenberghe, C. Leborgne, Y. Fromes, 2020, Scientific Reports.

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.

C. Leborgne, S. Boutin, O. Benveniste, 2010, Human gene therapy.

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

Laurence Zitvogel, Sebastian Amigorena, Florence Faure, 2001, Nature Medicine.

Dendritic Cells Route Human Immunodeficiency Virus to Lymph Nodes after Vaginal or Intravenous Administration to Mice

D. Klatzmann, N. Guettari, B. Salomon, 1998, Journal of Virology.

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors

Laetitia van Wittenberghe, C. Leborgne, Y. Fromes, 2020, Scientific Reports.

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy

Thomas Voit, Jean-Yves Hogrel, Laurent Servais, 2017, Nature Communications.

Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide

J. Davoust, F. Lemonnier, A. Kichler, 2019, Scientific Reports.

Soluble TNF-α receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer

D. Scherman, P. Bigey, A. Kichler, 2010, Gene Therapy.

Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.

C. Leborgne, S. Boutin, F. Mingozzi, 2019, Cellular immunology.

Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors

C. Leborgne, S. Boutin, P. Véron, 2012, Journal of Immunology.